Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02644083 · ClinicalTrials.gov registry record
Tecfidera and MRI for Brain Energy in MS
A clinical trial, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- 4
- Enrollment target
NCT02644083: Clinical Trial study, sponsored by Oregon Health and Science University.
NCT02644083 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02644083 was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The primary objective of this study is to test the hypothesis that DMF can improve mitochondrial function in the brain of people with MS. The investigators will assess mitochondrial function in the cerebral grey matter by measuring PCr and ATP by 31P magnetic resonance spectroscopy (MRS) and NAA in NAWM by 1H MRS.
Primary Outcome
PCr levels evaluated by magnetic resonance spectroscopy
Interventions
- DRUG Dimethyl fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-07 |
Why NCT02644083 stopped before completion
NCT02644083 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dimethyl fumarate is the first listed.
NCT02644083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02644083 about?
NCT02644083 is a clinical study titled "Tecfidera and MRI for Brain Energy in MS". The primary objective of this study is to test the hypothesis that DMF can improve mitochondrial function in the brain of people with MS. The investigators will assess mitochondrial function in the cerebral grey matter by measuring PCr and ATP by 31P magnetic resonance spectroscopy (MRS) and NAA in ...
What is the current status of trial NCT02644083?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2016-02. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02644083?
The interventions under investigation include: Dimethyl fumarate (DRUG).
Who is sponsoring clinical trial NCT02644083?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia